PROCEPT BioRobotics (PRCT) Gains from Investment Securities (2020 - 2021)

PROCEPT BioRobotics' (PRCT) quarterly Gains from Investment Securities came in at -$38000.0 in Q4 2021, down 179.17% year-on-year from $48000.0 in Q4 2020, and down 137.5% on a QoQ basis from -$16000.0 in Q3 2021.

PROCEPT BioRobotics (PRCT) Gains from Investment Securities (2020 - 2021) Analysis & Trends

PROCEPT BioRobotics (PRCT) has 2 years of Gains from Investment Securities data on file, last reported at -$38000.0 in Q4 2021.

  • On a quarterly basis, Gains from Investment Securities fell 179.17% year-over-year to -$38000.0 in Q4 2021; TTM through Mar 2022 was -$78000.0, a N/A change from a year earlier, with the FY2021 full-year figure at -$64000.0, up 65.41% from the prior year.
  • Gains from Investment Securities for Q4 2021 stood at -$38000.0, down from -$16000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for PRCT reached as high as $48000.0 in Q4 2020 and fell as low as -$142000.0 in Q3 2020.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 PROCEPT BioRobotics 1.00 Bn 757.43 Mn 53.95 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 -38,000.00
Dec 31, 2021 -38,000.00
Sep 30, 2021 -16,000.00
Sep 30, 2021 -16,000.00
Mar 31, 2021 -24,000.00
Mar 31, 2021 -24,000.00
Dec 31, 2020 48,000.00
Dec 31, 2020 48,000.00
Sep 30, 2020 -142,000.00
Sep 30, 2020 -142,000.00